Image

Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Testing a single eye injection for Retinitis Pigmentosa safety.

Recruiting
18-60 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)
Study Overview: This study looks at the safety of giving a single shot of jCell (famzeretcel). jCell contains 6 million special cells called retinal progenitor cells. The study lasts six months and checks the impact on people with a condition called Retinitis Pigmentosa (RP), which affects vision. Key Terms:
  • Retinitis Pigmentosa (RP): A disease causing vision problems, like losing side vision and trouble seeing at night.
  • Intravitreal Injection: A method of delivering medicine directly into the eye.
  • Sham-treated Controls: A group in the study that receives a fake treatment for comparison.
Key Points:
  • The study requires several visits and lasts 6 months.
  • Participants will receive one injection and need to follow study instructions.
  • Participants must be willing to travel and commit to all study requirements.
Note: Individuals must be between 18 and 60 years old, have a clinical diagnosis of RP, and be able to travel for the study. No recent participation in other drug trials, except for a specific allowed treatment, is permitted. Women of childbearing age must use birth control for a year after treatment.
Print
Study details
    Retinitis Pigmentosa

NCT06912633

jCyte, Inc

25 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race*
Are you a healthy volunteer
Ethnicity*
Are you a healthy volunteer
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.